French study tracks Real-World safety of automated insulin system
NCT ID NCT07211126
Summary
This study will monitor the safety and performance of an automated insulin delivery system (Control-IQ) in 350 people with type 1 diabetes in France. It aims to see how well the system controls blood sugar and improves quality of life during everyday use over 12 months. The study will track serious complications and how often people use the device.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.